Centerline Biomedical's last reported valuation, Jun 2022. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Centerline Biomedical: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Centerline Biomedical funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2025 | Early Stage VC | $10.8M | ▮ | ▮ |
| Feb 2022 | Early Stage VC | $34.7M | ▮ | ▮ |
| Aug 2019 | Early Stage VC | $12.7M | ▮ | ▮ |
| Aug 2015 | Early Stage VC | $13.7M | ▮ | ▮ |
Membership and data by Private Market View
Centerline Biomedical valuation
Centerline Biomedical's last reported valuation was $67.2 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.
How much has Centerline Biomedical raised?
Centerline Biomedical has raised $79.4 million across 4 recorded rounds since 2015. The largest was a $34.7 million early-stage round in Feb 2022; the most recent was a $10.8 million early-stage round in Apr 2025.
Centerline Biomedical has filed 4 Form Ds with the SEC since 2023, most recently in Apr 2025 ($10.8 million sold to 8 investors).
How Centerline Biomedical's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Centerline Biomedical, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Centerline Biomedical
- What is Centerline Biomedical worth?
- Centerline Biomedical is valued at $67.2M as of Oct 2026. Centerline Biomedical's last reported valuation, Jun 2022. Nothing priced has surfaced since.
- How much has Centerline Biomedical raised?
- Centerline Biomedical has raised $79.4M in total funding across 4 recorded rounds.
- When did Centerline Biomedical last raise?
- Centerline Biomedical last raised in Apr 2025 (Early Stage VC), raising $10.8M.